More than forty years later, in 1968, Samter and Beer fully described the clinical syndrome characterized by CRSwNP, asthma and hypersensitivity to aspirin and cyclooxygenase-1 (COX-1) inhibitors (2, 3). This evidence concerns the gene PTGS1 and chronic rhinosinusitis with nasal polyps.